Elevance Health, Inc. ELV

Full chart Compare
Set alert

Price alert · ELV

All alert types
434.18 USD +20.43 (+4.94%)

At closeNov 4, 2026, 4:13 PM EST

431.82 -2.36 -0.54%

After hours · Nov 4, 4:13 PM ET

412.06 Day range 437.94
274.84 52-week range 450.69
YTD
+23.86%
1 year
+37.13%

Financial health

Altman Z-Score

3.03 Safe zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

7 / 9 Strong

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

A-4 / 5 overall

  • DCF 5
  • Return on Equity 4
  • Return on Assets 4
  • Debt / Equity 1
  • P/E 3
  • P/B 3

Valuation

P/E 13.9×
FY 2016: 15.3×FY 2017: 15.3×FY 2018: 18.1×FY 2019: 16.1×FY 2020: 17.6×FY 2021: 18.4×FY 2022: 20.9×FY 2023: 18.6×FY 2024: 14.3×FY 2025: 13.9×
FY 2016 5y median 18.4× FY 2025
P/S 0.4×
FY 2016: 0.4×FY 2017: 0.6×FY 2018: 0.7×FY 2019: 0.7×FY 2020: 0.7×FY 2021: 0.8×FY 2022: 0.8×FY 2023: 0.6×FY 2024: 0.5×FY 2025: 0.4×
FY 2016 5y median 0.6× FY 2025
P/B 1.8×
FY 2016: 1.5×FY 2017: 2.2×FY 2018: 2.3×FY 2019: 2.4×FY 2020: 2.4×FY 2021: 3.1×FY 2022: 3.4×FY 2023: 2.8×FY 2024: 2.1×FY 2025: 1.8×
FY 2016 5y median 2.8× FY 2025
P/FCF 24.5×
FY 2016: 14.5×FY 2017: 17.0×FY 2018: 25.5×FY 2019: 15.5×FY 2020: 8.3×FY 2021: 15.5×FY 2022: 17.0×FY 2023: 16.2×FY 2024: 18.9×FY 2025: 24.5×
FY 2016 5y median 17.0× FY 2025
EV/EBITDA 10.5×
FY 2016: 8.0×FY 2017: 13.2×FY 2018: 11.8×FY 2019: 11.9×FY 2020: 11.8×FY 2021: 13.3×FY 2022: 14.0×FY 2023: 12.4×FY 2024: 10.5×FY 2025: 10.5×
FY 2016 5y median 12.4× FY 2025
EV/Sales 0.5×
FY 2016: 0.6×FY 2017: 0.8×FY 2018: 0.9×FY 2019: 0.9×FY 2020: 0.8×FY 2021: 1.0×FY 2022: 0.9×FY 2023: 0.8×FY 2024: 0.6×FY 2025: 0.5×
FY 2016 5y median 0.8× FY 2025
FCF Yield 4.1%
FY 2016: 6.9%FY 2017: 5.9%FY 2018: 3.9%FY 2019: 6.5%FY 2020: 12.0%FY 2021: 6.4%FY 2022: 5.9%FY 2023: 6.2%FY 2024: 5.3%FY 2025: 4.1%
FY 2016 5y median 5.9% FY 2025

Profitability

Gross Margin 25.6%
FY 2016: 21.4%FY 2017: 19.8%FY 2018: 21.9%FY 2019: 21.5%FY 2020: 27.8%FY 2021: 26.0%FY 2022: 25.5%FY 2023: 27.4%FY 2024: 27.9%FY 2025: 25.6%
FY 2016 5y median 26.0% FY 2025
Operating Margin 4.1%
FY 2016: 6.4%FY 2017: 5.5%FY 2018: 6.3%FY 2019: 6.5%FY 2020: 6.3%FY 2021: 6.5%FY 2022: 5.4%FY 2023: 5.1%FY 2024: 5.0%FY 2025: 4.1%
FY 2016 5y median 5.1% FY 2025
Net Margin 2.8%
FY 2016: 2.9%FY 2017: 4.3%FY 2018: 4.1%FY 2019: 4.6%FY 2020: 3.8%FY 2021: 4.4%FY 2022: 3.8%FY 2023: 3.5%FY 2024: 3.4%FY 2025: 2.8%
FY 2016 5y median 3.5% FY 2025
ROE 12.9%
FY 2016: 9.8%FY 2017: 14.5%FY 2018: 13.1%FY 2019: 15.2%FY 2020: 13.8%FY 2021: 16.9%FY 2022: 16.3%FY 2023: 15.2%FY 2024: 14.5%FY 2025: 12.9%
FY 2016 5y median 15.2% FY 2025
ROIC 6.6%
FY 2016: 5.0%FY 2017: 7.6%FY 2018: 6.6%FY 2019: 7.8%FY 2020: 7.3%FY 2021: 8.2%FY 2022: 7.6%FY 2023: 7.4%FY 2024: 6.7%FY 2025: 6.6%
FY 2016 5y median 7.4% FY 2025
ROA 4.7%
FY 2016: 3.7%FY 2017: 5.4%FY 2018: 5.2%FY 2019: 6.1%FY 2020: 5.2%FY 2021: 6.3%FY 2022: 5.7%FY 2023: 5.5%FY 2024: 5.1%FY 2025: 4.7%
FY 2016 5y median 5.5% FY 2025

Growth (YoY)

Revenue 12.6%
FY 2016: 7.2%FY 2017: 6.0%FY 2018: 2.3%FY 2019: 13.1%FY 2020: 16.9%FY 2021: 13.8%FY 2022: 13.0%FY 2023: 9.4%FY 2024: 3.2%FY 2025: 12.6%
FY 2016 FY 2025
Operating Income -8.7%
FY 2016: 1.1%FY 2017: -8.0%FY 2018: 17.1%FY 2019: 15.4%FY 2020: 14.5%FY 2021: 16.0%FY 2022: -5.5%FY 2023: 3.5%FY 2024: 1.6%FY 2025: -8.7%
FY 2016 FY 2025
EPS (diluted) -2.2%
FY 2016: -1.8%FY 2017: 55.8%FY 2018: -1.1%FY 2019: 30.2%FY 2020: -2.7%FY 2021: 37.5%FY 2022: -1.8%FY 2023: 3.9%FY 2024: 1.8%FY 2025: -2.2%
FY 2016 FY 2025
Free Cash Flow -30.3%
FY 2016: -25.4%FY 2017: 29.5%FY 2018: -22.8%FY 2019: 90.3%FY 2020: 94.0%FY 2021: -24.7%FY 2022: -0.4%FY 2023: -6.7%FY 2024: -32.7%FY 2025: -30.3%
FY 2016 FY 2025

Financial Health

Current Ratio 1.2×
FY 2016: 1.1×FY 2017: 0.9×FY 2018: 1.1×FY 2019: 1.1×FY 2020: 1.1×FY 2021: 0.9×FY 2022: 1.0×FY 2023: 1.0×FY 2024: 1.1×FY 2025: 1.2×
FY 2016 5y median 1.0× FY 2025
Quick Ratio 1.2×
FY 2016: 1.1×FY 2017: 0.9×FY 2018: 1.1×FY 2019: 1.1×FY 2020: 1.1×FY 2021: 0.9×FY 2022: 1.0×FY 2023: 1.0×FY 2024: 1.1×FY 2025: 1.2×
FY 2016 5y median 1.0× FY 2025
Debt / Equity 0.8×
FY 2016: 0.6×FY 2017: 0.8×FY 2018: 0.7×FY 2019: 0.7×FY 2020: 0.7×FY 2021: 0.7×FY 2022: 0.7×FY 2023: 0.7×FY 2024: 0.8×FY 2025: 0.8×
FY 2016 5y median 0.7× FY 2025
Net Debt / EBITDA 2.5×
FY 2016: 1.9×FY 2017: 2.9×FY 2018: 2.2×FY 2019: 2.1×FY 2020: 2.0×FY 2021: 2.0×FY 2022: 1.8×FY 2023: 1.9×FY 2024: 2.3×FY 2025: 2.5×
FY 2016 5y median 2.0× FY 2025
Interest Coverage 5.8×
FY 2016: 7.5×FY 2017: 6.7×FY 2018: 7.8×FY 2019: 9.0×FY 2020: 9.8×FY 2021: 11.2×FY 2022: 9.9×FY 2023: 8.5×FY 2024: 7.5×FY 2025: 5.8×
FY 2016 5y median 8.5× FY 2025

Dividends

Dividend Yield 2.0%
FY 2016: 1.8%FY 2017: 1.2%FY 2018: 1.2%FY 2019: 1.1%FY 2020: 1.2%FY 2021: 1.0%FY 2022: 1.0%FY 2023: 1.3%FY 2024: 1.8%FY 2025: 2.0%
FY 2016 5y median 1.3% FY 2025
Payout Ratio 27.0%
FY 2016: 27.7%FY 2017: 18.3%FY 2018: 20.7%FY 2019: 17.0%FY 2020: 20.9%FY 2021: 18.1%FY 2022: 20.9%FY 2023: 23.3%FY 2024: 25.2%FY 2025: 27.0%
FY 2016 5y median 23.3% FY 2025

Annual · latest fiscal year ends 2025-12-31